| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.08 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.05 | 0.08 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.09 |